OMEZ 40 + OMEZ 80
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedAbout OMEZ 40 + OMEZ 80
OMEZ 40 + OMEZ 80 is a approved stage product being developed by Dr. Reddy's Laboratories for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT02922699. Target conditions include GERD.
What happened to similar drugs?
8 of 20 similar drugs in GERD were approved
Approved (8) Terminated (0) Active (12)
Hype Score Breakdown
Clinical
20
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02922699 | Approved | Completed |
Competing Products
20 competing products in GERD
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| omeprazole+domperidone SR + omeprazole | Dr. Reddy's Laboratories | Approved | 36 |
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | 40 |
| Rabeprazole sodium | Eisai | Phase 1 | 29 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 40 |
| rabeprazole sodium + Placebo | Eisai | Phase 3 | 40 |
| Rabeprazole ER + Ranitidine | Eisai | Phase 3 | 40 |
| Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mg | Eisai | Phase 1 | 29 |
| rabeprazole + rabeprazole | Eisai | Phase 3 | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 40 |
| Rabeprazole sodium + Esomeprazole | Eisai | Phase 3 | 40 |
| ONO-8539 | Ono Pharmaceutical | Phase 1 | 29 |
| esomeprazole 40 mg | Johnson & Johnson | Pre-clinical | 26 |
| esomeprazole (Nexium®) + Xolaam® | AstraZeneca | Approved | 43 |
| esomeprazole | AstraZeneca | Pre-clinical | 26 |
| Esomeprazole | AstraZeneca | Approved | 43 |
| Esomeprazole | AstraZeneca | Approved | 43 |
| esomeprazole magnesium | AstraZeneca | Phase 1 | 29 |
| Esomeprazole | AstraZeneca | Approved | 43 |
| Esomeprazole | AstraZeneca | Phase 3 | 40 |
| Esomeprazole (Nexium) | AstraZeneca | Approved | 43 |